Clinical development activity in perspective 

A head-to-head comparison of Pharma and CRO phase I-IV activities.

When you think about it, spending on phase I-IV services by pharma sponsors is roughly equivalent to revenue generated by CROs. One company’s expense is another company’s revenue. ISR wanted to see how the largest public CROs stacked up to the largest pharma companies in terms of their phase I-IV activities.

Date: June 9, 2014

Download this File